390 related articles for article (PubMed ID: 17323586)
1. Olmesartan medoxomil: current status of its use in monotherapy.
Brunner HR
Vasc Health Risk Manag; 2006; 2(4):327-40. PubMed ID: 17323586
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.
Malacco E; Omboni S; Mallion JM; Volpe M;
High Blood Press Cardiovasc Prev; 2012 Dec; 19(4):213-22. PubMed ID: 23430666
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
Volpe M; Brommer P; Haag U; Miele C
Clin Drug Investig; 2009; 29(1):11-25. PubMed ID: 19067471
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study.
Barrios V; Boccanelli A; Ewald S; Girerd X; Heagerty A; Krzesinski JM; Lins R; Rodicio J; Stefenelli T; Woittiez A; Böhm M
Clin Drug Investig; 2007; 27(8):545-58. PubMed ID: 17638395
[TBL] [Abstract][Full Text] [Related]
5. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.
Smith DH; Dubiel R; Jones M
Am J Cardiovasc Drugs; 2005; 5(1):41-50. PubMed ID: 15631537
[TBL] [Abstract][Full Text] [Related]
6. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.
Barrios V; Brommer P; Haag U; Calderón A; Escobar C
Clin Drug Investig; 2009; 29(7):427-439. PubMed ID: 19499960
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension.
Chrysant SG; Lee J; Melino M; Karki S; Heyrman R
J Hum Hypertens; 2010 Nov; 24(11):730-8. PubMed ID: 20164847
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive effects of olmesartan compared with other angiotensin receptor blockers: a meta-analysis.
Wang L; Zhao JW; Liu B; Shi D; Zou Z; Shi XY
Am J Cardiovasc Drugs; 2012 Oct; 12(5):335-44. PubMed ID: 22920046
[TBL] [Abstract][Full Text] [Related]
9. Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension.
Greathouse M
Vasc Health Risk Manag; 2006; 2(4):401-9. PubMed ID: 17323594
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
Chrysant SG; Chavanu KJ; Xu J
Am J Cardiovasc Drugs; 2009; 9(4):241-51. PubMed ID: 19655819
[TBL] [Abstract][Full Text] [Related]
11. Olmesartan medoxomil evaluated for safety and efficacy in Indian patients with essential hypertension: a real world observational postmarketing surveillance.
Rana R; Singh A
J Assoc Physicians India; 2010 Feb; 58():77-83. PubMed ID: 20653147
[TBL] [Abstract][Full Text] [Related]
12. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
Mallion JM; Heagerty A; Laeis P
J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
[TBL] [Abstract][Full Text] [Related]
13. Olmesartan medoxomil: a review of its use in the management of hypertension.
Scott LJ; McCormack PL
Drugs; 2008; 68(9):1239-72. PubMed ID: 18547134
[TBL] [Abstract][Full Text] [Related]
14. Olmesartan/amlodipine: a review of its use in the management of hypertension.
Kreutz R
Vasc Health Risk Manag; 2011; 7():183-92. PubMed ID: 21490944
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
[TBL] [Abstract][Full Text] [Related]
16. Effective systolic blood pressure reduction with olmesartan medoxomil/amlodipine combination therapy: post hoc analysis of data from a randomized, double-blind, parallel-group, multicentre study.
Mourad JJ; Le Jeune S
Clin Drug Investig; 2009; 29(6):419-25. PubMed ID: 19432501
[TBL] [Abstract][Full Text] [Related]
17. Olmesartan medoxomil in elderly patients with essential or isolated systolic hypertension : efficacy and safety data from clinical trials.
Heagerty AM; Mallion JM
Drugs Aging; 2009; 26(1):61-76. PubMed ID: 19102515
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study.
Barrios V; Escobar C; Calderon A; Böhm M
Vasc Health Risk Manag; 2009; 5():723-9. PubMed ID: 19756164
[TBL] [Abstract][Full Text] [Related]
19. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
Chrysant SG
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
[TBL] [Abstract][Full Text] [Related]
20. Olmesartan medoxomil.
Warner GT; Jarvis B
Drugs; 2002; 62(9):1345-53; discussion 1354-6. PubMed ID: 12076183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
